Amarin Corp Plc (AMRN)

[jessellivermore]

DISCLOSURE

So far we have done a great deal of speculating on why a prescribed sixty day period to settle whether Amarin will continue its 1A legal case, has been stretched out to six months. The crux of the situation is continuance of the trial could (and probably would) tar the FDA with a indelible judgment which would curtail the FDA's powers. The safe conclusion being the FDA would avoid this at all costs.

So far the company has been evasive about the reasons for the extension of the delay period. The CEO's comments on the settlement were

"It would not be appropriate or constructive at this time for us to characterize the substance of such settlement negotiations, other than to say that we’re working with the government to resolve the case completely and we don’t expect that process to alter our current path, expanding the promotion of Vascepa to healthcare professionals."

The question I put before you...is As shareholders with a stake (our money) is why doesn't the company tell us what is going on here and what are the difficulties. This is clearly a disclosure issue. To tell us they are working with government is no information. Is it the FDA is too slow?...are there problems with R-I? Has the company decided the settlement is no longer a priority...What are the reasons.

As owners of the company we have the right to know what's going on here, and stop all this guessing on our part. Unexpected material events are subject to disclosure laws and this issue clearly falls that heading..This is not Top Secret information that would compromise the state...We need some answers.

":>) JL